We have evolved our ways of working throughout the global health crisis, ensuring that our processes, people and technologies support vaccines in the marketplace and keep patients in clinical trials. To remain committed to this goal, we are actively recruiting to ensure that the vital work of developing and delivering new therapies to patients worldwide continues.